|
1
|
Sui H, Cai GX, Pan SF, Deng WL, Wang YW,
Chen ZS, Cai SJ, Zhu HR and Li Q: miR200c attenuates P-gp-mediated
MDR and metastasis by targeting JNK2/c-Jun signaling pathway in
colorectal cancer. Mol Cancer Ther. 13:3137–3151. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sui H, Zhu L, Deng W and Li Q:
Epithelial-mesenchymal transition and drug resistance: Role,
molecular mechanisms, and therapeutic strategies. Oncol Res Treat.
37:584–589. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang YK, Zhang GN, Wang YJ, Patel BA,
Talele TT, Yang DH and Chen ZS: Bafetinib (INNO-406) reverses
multidrug resistance by inhibiting the efflux function of ABCB1 and
ABCG2 transporters. Sci Rep. 6:256942016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nüsslein-Volhard C and Wieschaus E:
Mutations affecting segment number and polarity in
Drosophila. Nature. 287:795–801. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee RT, Zhao Z and Ingham PW: Hedgehog
signalling. Development. 143:367–372. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Flemban A and Qualtrough D: The potential
role of Hedgehog signaling in the luminal/basal phenotype of breast
epithelia and in breast cancer invasion and metastasis. Cancers
(Basel). 7:1863–1884. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Laukkanen MO and Castellone MD: Hijacking
the Hedgehog pathway in cancer therapy. Anticancer Agents Med Chem.
16:309–317. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kling JC and Blumenthal A: Roles of WNT,
NOTCH, and Hedgehog signaling in the differentiation and function
of innate and innate-like lymphocytes. J Leukoc Biol jlb.
1MR0616-272R. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xie J, Bartels CM, Barton SW and Gu D:
Targeting Hedgehog signaling in cancer: Research and clinical
developments. Onco Targets Ther. 6:1425–1435. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lee MY, Sun L and Veltmaat JM: Hedgehog
and Gli signaling in embryonic mammary gland development. J Mammary
Gland Biol Neoplasia. 18:133–138. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shevde LA and Samant RS: Nonclassical
Hedgehog-GLI signaling and its clinical implications. Int J Cancer.
135:1–6. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Malhotra GK, Zhao X, Band H and Band V:
Shared signaling pathways in normal and breast cancer stem cells. J
Carcinog. 10:382011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li WY, Chan SW, Guo DJ, Chung MK, Leung TY
and Yu PH: Water extract of Rheum officinale Baill. induces
apoptosis in human lung adenocarcinoma A549 and human breast cancer
MCF-7 cell lines. J Ethnopharmacol. 124:251–256. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rasul A, Yu B, Yang LF, Ali M, Khan M, Ma
T and Yang H: Induction of mitochondria-mediated apoptosis in human
gastric adenocarcinoma SGC-7901 cells by kuraridin and
Nor-kurarinone isolated from Sophora flavescens. Asian Pac J Cancer
Prev. 12:2499–2504. 2011.PubMed/NCBI
|
|
15
|
Sui H, Zhu HR, Wu J, Nikitin AY, Cai JF,
Fan ZZ and Li Q: Effects of Jianpi Jiedu Recipe on reversion of
P-glycoprotein-mediated multidrug resistance through COX-2 pathway
in colorectal cancer. Chin J Integr Med. 20:610–617. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sun B, Chen Y, Xiang T, Zhang L, Chen Z,
Zhang S, Zhou H and Chen S: The Chinese herb Jianpijiedu
contributes to the regulation of OATP1B2 and ABCC2 in a rat model
of orthotopic transplantation liver cancer pretreated with food
restriction and diarrhea. BioMed Res Int. 2015:7528502015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sui H, Liu X, Jin BH, Pan SF, Zhou LH, Yu
NA, Wu J, Cai JF, Fan ZZ, Zhu HR, et al: Zuo Jin Wan, a traditional
Chinese herbal formula, reverses P-gp-mediated MDR in vitro and in
vivo. Evid Based Complement Alternat Med. 2013:9570782013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sui H, Xu H, Ji Q, Liu X, Zhou L, Song H,
Zhou X, Xu Y, Chen Z, Cai J, et al: 5-hydroxytryptamine receptor
(5-HT1DR) promotes colorectal cancer metastasis by regulating
Axin1/β-catenin/MMP-7 signaling pathway. Oncotarget. 6:25975–25987.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kolinsky K, Shen BQ, Zhang YE, Kohles J,
Dugan U, Zioncheck TF, Heimbrook D, Packman K and Higgins B: In
vivo activity of novel capecitabine regimens alone and with
bevacizumab and oxaliplatin in colorectal cancer xenograft models.
Mol Cancer Ther. 8:75–82. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Martins A, Sipos P, Dér K, Csábi J, Miklos
W, Berger W, Zalatnai A, Amaral L, Molnár J, Szabó-Révész P, et al:
Ecdysteroids sensitize MDR and non-MDR cancer cell lines to
doxorubicin, paclitaxel, and vincristine but tend to protect them
from cisplatin. BioMed Res Int. 2015:8953602015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang S, Wang L, Shi Z, Zhong Z, Chen M and
Wang Y: Evodiamine synergizes with doxorubicin in the treatment of
chemoresistant human breast cancer without inhibiting
P-glycoprotein. PLoS One. 9:e975122014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang Z, Sun X, Feng Y, Liu X, Zhou L, Sui
H, Ji QeQ, Chen J, Wu L, et al: Dihydromyricetin reverses
MRP2-mediated MDR and enhances anticancer activity induced by
oxaliplatin in colorectal cancer cells. Anticancer Drugs.
28:281–288. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sharom FJ: ABC multidrug transporters:
Structure, function and role in chemoresistance. Pharmacogenomics.
9:105–127. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wilkens S: Structure and mechanism of ABC
transporters. F1000Prime Rep. 7:142015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Deng W, Sui H, Wang Q, He N, Duan C, Han
L, Li Q, Lu M and Lv S: A Chinese herbal formula, Yi-Qi-Fu-Sheng,
inhibits migration/invasion of colorectal cancer by down-regulating
MMP-2/9 via inhibiting the activation of ERK/MAPK signaling
pathways. BMC Complement Altern Med. 13:652013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cao P, Selvan SR, Akkol Küpeli E, Wang N,
Yang H and Cheng X: Complementary and alternative medicine in
cancer prevention and therapy. Evid Based Complement Alternat Med.
2015:6393722015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yao CJ, Chow JM, Yang CM, Kuo HC, Chang
CL, Lee HL, Lai IC, Chuang SE and Lai GM: Chinese herbal mixture,
Tien-Hsien liquid, induces G2/M cycle arrest and radiosensitivity
in MCF-7 human breast cancer cells through mechanisms involving
DNMT1 and Rad51 downregulation. Evid Based Complement Alternat Med.
2016:32510462016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen T, Wang Q, Li Y, Huang H and Hu W:
Chinese herbal formula QHF inhibits liver cancer cell invasion and
migration. Exp Ther Med. 11:2413–2419. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li J, Sun GZ, Lin HS, Pei YX, Qi X, An C,
Yu J and Hua BJ: The herb medicine formula ‘Yang Wei Kang Liu’
improves the survival of late stage gastric cancer patients and
induces the apoptosis of human gastric cancer cell line through
Fas/Fas ligand and Bax/Bcl-2 pathways. Int Immunopharmacol.
8:1196–1206. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wu G, Chu J, Huang Z, Ye J, Chen P, Zheng
C, Li X, Liu X and Wu M: Xiao Jin Wan, a traditional Chinese herbal
formula, inhibits proliferation via arresting cell cycle
progression at the G2/M phase and promoting apoptosis via
activating the mitochondrial-dependent pathway in U-2OS human
osteosarcoma cells. Int J Oncol. 42:1070–1080. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sui H, Pan SF, Feng Y, Jin BH, Liu X, Zhou
LH, Hou FG, Wang WH, Fu XL, Han ZF, et al: Zuo Jin Wan reverses
P-gp-mediated drug-resistance by inhibiting activation of the
PI3K/Akt/NF-κB pathway. BMC Complement Altern Med. 14:2792014.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liang W, Wang H, Tang Y, Cai SB, Zhang X
and Wang SP: The effect and mechanism of Zhizhen Recipe on
multidrug resistance in human colorectal cancer cell lines through
Hedgehog signaling pathway. Chin J Integr Trad W Med Dig.
23:151–155. 2015.(In Chinese).
|
|
33
|
Zhang XL, Shi HJ, Wang JP, Tang HS and Cui
SZ: MiR-218 inhibits multidrug resistance (MDR) of gastric cancer
cells by targeting Hedgehog/smoothened. Int J Clin Exp Pathol.
8:6397–6406. 2015.PubMed/NCBI
|
